Cefalo, Consuelo
 Distribuzione geografica
Continente #
EU - Europa 745
NA - Nord America 540
AS - Asia 170
OC - Oceania 3
Totale 1.458
Nazione #
US - Stati Uniti d'America 536
DE - Germania 387
CN - Cina 115
SE - Svezia 107
UA - Ucraina 76
IT - Italia 39
FR - Francia 34
GB - Regno Unito 27
SG - Singapore 26
IE - Irlanda 25
FI - Finlandia 15
PL - Polonia 14
IN - India 12
RU - Federazione Russa 11
TR - Turchia 7
JP - Giappone 6
AU - Australia 3
CA - Canada 3
IR - Iran 3
NL - Olanda 3
BE - Belgio 2
CH - Svizzera 2
RO - Romania 2
CZ - Repubblica Ceca 1
IQ - Iraq 1
PR - Porto Rico 1
Totale 1.458
Città #
Chandler 141
Jacksonville 45
Ashburn 37
San Mateo 28
Dublin 25
Nanjing 24
Nürnberg 22
Wilmington 16
Ann Arbor 15
Dearborn 14
Kraków 14
Milan 14
New York 14
Boston 13
Houston 13
Woodbridge 13
Marseille 12
Munich 12
Tianjin 11
Zhengzhou 11
Nanchang 10
Singapore 10
Moscow 9
Fairfield 8
Los Angeles 8
Princeton 8
Shenyang 8
Bremen 7
Chicago 7
Izmir 7
Redwood City 7
Beijing 6
Lawrence 6
Cattolica 5
Cambridge 4
Kunming 4
Leawood 4
Shanghai 4
Boardman 3
Changsha 3
Guangzhou 3
Hebei 3
Jinan 3
Lancaster 3
Mountain View 3
Pune 3
Tokyo 3
Toronto 3
University Park 3
Amsterdam 2
Augusta 2
Bern 2
Brussels 2
Clayton 2
Como 2
Easton 2
Fremont 2
Hangzhou 2
Helsinki 2
Jiaxing 2
Norwalk 2
Orange 2
Rome 2
Seattle 2
Taizhou 2
Andover 1
Ardabil 1
Baghdad 1
Brno 1
Buffalo 1
Chengdu 1
Chongqing 1
Costa Mesa 1
Dalmine 1
Duncan 1
Esslingen am Neckar 1
Gunzenhausen 1
Haikou 1
Hefei 1
Kashan 1
Kish 1
Lanzhou 1
Ningbo 1
Perugia 1
Portland 1
Rotterdam 1
Saint Louis 1
San Diego 1
San Jose 1
Washington 1
Totale 706
Nome #
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 152
Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels 135
Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels 124
The Effect of CYP, GST, and SULT Polymorphisms and Their Interaction with Smoking on the Risk of Hepatocellular Carcinoma 118
Potential use of liver function breath tests in the clinical practice. 111
Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels 101
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome 99
Intrafamilial transmission of hepatitis C virus in Italy: a systematic review 96
A case-control study on the effects of the apolipoprotein E genotypes in nonalcoholic fatty liver disease 94
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome 93
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome 86
Gallstone disease is associated with more severe liver damage in patients with non-alcoholic Fatty liver disease 83
Alcoholic and nonalcoholic forms of fatty liver disease. 80
Enhanced liver fibrosis test as a reliable tool for assessing fibrosis in nonalcoholic fatty liver disease in a clinical setting 60
Serum levels of hyaluronic acid and tissue metalloproteinase inhibitor-1 combined with age predict the presence of nonalcoholic steatohepatitis in a pilot cohort of subjects with nonalcoholic fatty liver disease. 17
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 17
Totale 1.466
Categoria #
all - tutte 4.813
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.813


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020175 0 5 12 7 24 21 33 7 13 22 13 18
2020/2021145 2 15 20 19 14 11 13 2 18 8 21 2
2021/2022143 10 14 4 9 11 2 2 19 2 17 27 26
2022/2023326 36 50 22 67 11 43 15 28 42 4 6 2
2023/2024151 10 40 6 10 9 32 3 0 0 2 20 19
2024/202512 7 5 0 0 0 0 0 0 0 0 0 0
Totale 1.466